Restricted Research - Award List, Note/Discussion Page
Fiscal Year: 2023
1784 The University of Texas at El Paso (143672)
Principal Investigator: Lu,Weiqin
Total Amount of Contract, Award, or Gift (Annual before 2011): $ 1,032,327
Exceeds $250,000 (Is it flagged?): Yes
Start and End Dates: 10/1/22 - 8/31/25
Restricted Research: YES
Academic Discipline: Pharmaceutical Science
Department, Center, School, or Institute: Pharmaceutical Science
Title of Contract, Award, or Gift: R01: Targeting NADPH Oxidase for Pancreatic Cancer Prevention and Therapy
Name of Granting or Contracting Agency/Entity:
NIH - NATIONAL CANCER INSTITUTE
CFDA Link: HHS
93.396
Program Title:
Cancer Biology Research
CFDA Linked: Cancer Biology Research
Note:
RO1: Pancreatic cancer risk factors, including pancreatitis and obesogenic high-fat diet, conspire with mutant KRAS to promote PDAC with high penetrance; however, the underlying mechanism remains elusive. The objective of this proposal is to determine if NADPH oxidase is a critical mediator in this context.
Discussion: No discussion notes